450 filings
Page 21 of 23
424B3
zomo4jx v2dpbp
12 Mar 15
Prospectus supplement
12:00am
8-K
1cx5gawx
11 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
mxp0ip5h3u1q h2a5uc5
9 Mar 15
Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP
12:00am
424B3
pqy09p0lfwgz0z12om
26 Feb 15
Prospectus supplement
12:00am
EFFECT
3hwmlzj
13 Feb 15
Notice of effectiveness
12:00am
CORRESP
gknt knn8civqa
13 Feb 15
Correspondence with SEC
12:00am
CORRESP
p7ltny8q5a np7xy
12 Feb 15
Correspondence with SEC
12:00am
UPLOAD
h5nrofbv1alo7fvw3659
11 Feb 15
Letter from SEC
12:00am
8-K
ub99qsrjy8auo8a
5 Feb 15
Recro Pharma to Present at the 17th Annual BIO CEO & Investor
12:00am
8-K
630d8im 68d
3 Feb 15
Recro Pharma Enters into Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
cqvlbe2oh8itzx ms
19 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
eci5em6fo
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
fjc77d9uqccqcg15iwd7
30 Oct 14
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
12:00am
8-K
gindi2
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
tdp7qj73 bpu1ca2
4 Sep 14
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
12:00am
8-K
jqi0o
12 Aug 14
Recro Pharma Reports Second Quarter 2014 Financial Results
12:00am